OR
Orgenesis Inc.
ORGS · OTC
$0.59 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.78M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.91x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 58.93%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 10,445.50%
Op. margin 10,120.00%
FCF margin 3,194.91%
Quality
1 /100
Poor ROA 380.44%
Asset turnover 0.04x
ROIC 3,180.09%
Debt
0 /100
High Int. coverage -28.74x
Current ratio 0.25x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Rev. volatility 243.34%
EPS volatility 162.20%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ORGS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vered Caplan
Employees
77
Headquarters
Germantown
Upcoming events
11 NOV
Earnings
Upcoming earnings report